Probiotics: the potential for a live microbicide to prevent HIV - PubMed (original) (raw)

Probiotics: the potential for a live microbicide to prevent HIV

Anke Hemmerling et al. J Acquir Immune Defic Syndr. 2011.

No abstract available

PubMed Disclaimer

Similar articles

• Report from the 16th Conference on Retroviruses and Opportunistic Infections. First (sort of) positive anti-HIV microbicide trial.
  del Rio C. del Rio C. J Watch AIDS Clin Care. 2009 Apr;21(4):34. J Watch AIDS Clin Care. 2009. PMID: 19544618 No abstract available.
• 'We need a microbicide now!'.
  Smart T. Smart T. IAPAC Mon. 2006 Apr;12(4):114. IAPAC Mon. 2006. PMID: 17233098 No abstract available.
• Microbicide trial highly disappointing.
  [No authors listed] [No authors listed] HIV Prev Plus. 2000 Sep;2(1):3. HIV Prev Plus. 2000. PMID: 11668703 No abstract available.
• Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers.
  Doncel GF, Clark MR. Doncel GF, et al. Antiviral Res. 2010 Dec;88 Suppl 1:S10-8. doi: 10.1016/j.antiviral.2010.09.018. Antiviral Res. 2010. PMID: 21109063 Review.
• Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide.
  Bélec L, Jenabian MA, Charpentier C, Saïdi H. Bélec L, et al. Future Microbiol. 2011 Jul;6(7):731-7. doi: 10.2217/fmb.11.64. Future Microbiol. 2011. PMID: 21797688 Review.

Cited by

• The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.
  Abdool Karim SS, Baxter C, Passmore JS, McKinnon LR, Williams BL. Abdool Karim SS, et al. J Int AIDS Soc. 2019 May;22(5):e25300. doi: 10.1002/jia2.25300. J Int AIDS Soc. 2019. PMID: 31144462 Free PMC article. Review.
• Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.
  Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. Cohen CR, et al. PLoS Med. 2012;9(6):e1001251. doi: 10.1371/journal.pmed.1001251. Epub 2012 Jun 26. PLoS Med. 2012. PMID: 22745608 Free PMC article.
• The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization.
  Balkus JE, Jaoko W, Mandaliya K, Richardson BA, Masese L, Gitau R, Kiarie J, Marrazzo J, Farquhar C, McClelland RS. Balkus JE, et al. Sex Transm Dis. 2012 May;39(5):361-5. doi: 10.1097/OLQ.0b013e31824790d7. Sex Transm Dis. 2012. PMID: 22504600 Free PMC article. Clinical Trial.

References

1. 1. Karim QA, Karim SS, Frohlich JA on behalf of the CAPRISA 004 Trial Group. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science. 2010 Jul 19; [Epub ahead of print] - PMC - PubMed
2. 1. VOICE Trial (MPT-003) http://www.mtnstopshiv.org/news/studies/mtn003.
3. 1. FDA and CONRAD Chart U.S. Regulatory Path for 1% Tenofovir Gel for HIV Prevention. 2010 Oct 25; http://www.avac.org/ht/a/GetDocumentAction/i/30649.
4. 1. Macintyre K, Rutenberg N, Brown L, et al. Understanding Perceptions of HIV Risk among Adolescents in KwaZulu-Natal. MEASURE Evaluation project WP 03-72. 2003 http://info.k4health.org/youthwg/PDFs/MeasureEval/wp-03-72.pdf. - PubMed
5. 1. Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006;8(6):1450–1454. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information